Services

Sandoz offers outstanding contract services for recombinant peptides and proteins.

The technical development group understands the needs of large scale manufacturing. It’s teams are committed to use integrated development approaches comprising all stages of product development from cloning to formulation with the goal to combine innovation and process economics.

With the proprietary Npro Autoprotease Fusion Technology (NAFT)  Sandoz developed a tool for improved expression and isolation of fusion proteins. This system leads to controllable, quantitative and autoproteolytic cleavage resulting in an authentic N-terminus. This effective and high yielding expression technology is a complement to our production technology and offers a highly cost competitive option for the manufacture of peptides and proteins.

Our broad range of facilities for recombinant microbial products allows to develop and scale up processes and to manufacture material in quantities to cover needs ranging from pre-clinical use through all clinical stages to commercial supply. This includes services for development and production of active substance and finished product including quality, analytical and regulatory support.

Also the cell culture facilities of Sandoz are capable of generating quantities of product to serve all stages of clinical development and to supply commercial product.

Sandoz is offering  state-of-the-art analytical services to accompany all stages of process development and commercial scale manufacturing. Our competent and highly qualified experts provide excellent technical expertise and know-how in testing and characterization of recombinant proteins.